Host-Microbe Interactions and Pathogenesis

Overview of Host-Microbe Interactions

Host-microbe interactions are fundamental to human health and disease. The human body is colonized by a diverse community of microbes, known as the normal microbiota, which play essential roles in maintaining physiological balance.

• Normal microbiota: Microorganisms that inhabit the skin, digestive, respiratory, genital, and urinary systems, contributing to health by outcompeting pathogens and aiding in immune system development.

• Mutualism: A symbiotic relationship where both host and microbe benefit. For example, gut bacteria synthesize vitamins and help train the immune system.

• Dysbiosis: Disruption of the normal microbiota, often due to antibiotics, which can allow opportunistic pathogens (e.g., Clostridium difficile) to proliferate and cause disease.

Example: Antibiotic treatment can disrupt gut microbiota, leading to overgrowth of Clostridium difficile and resulting in severe diarrhea.

Pathogens, Opportunists, and Disease States

Pathogens are microbes capable of causing disease, but their ability to do so depends on both microbial and host factors. Some microbes are opportunistic, causing disease only when host defenses are compromised.

• Pathogens: Microbes with adaptations for infecting host tissues and causing disease.

• Opportunistic pathogens: Normally harmless microbes that cause disease when host immunity is weakened (e.g., Candida albicans).

• Tropism: The preference of a pathogen for a specific host or tissue type, which can evolve and lead to emerging diseases.

Example: Candida albicans is part of the normal microbiota but can cause infections in immunocompromised individuals.

Pathogenicity, Virulence, and Virulence Factors

Pathogenicity and virulence describe a microbe's disease-causing potential and severity. Virulence factors are specific traits that enable pathogens to infect, damage, and evade host defenses.

• Pathogenicity: The ability of a microbe to cause disease.

• Virulence: The degree or severity of disease caused by a microbe.

• Virulence factors: Molecules or structures that help pathogens adhere, invade, acquire nutrients, evade immunity, and transmit to new hosts (e.g., toxins, enzymes, capsules).

Example: The capsule of Streptococcus pneumoniae helps it evade phagocytosis by immune cells.

Infectious Dose, Lethal Dose, and R-naught (R₀)

Quantitative measures help assess the infectivity, toxicity, and epidemic potential of pathogens.

• ID50 (Infectious Dose-50): The number of microbes required to infect 50% of exposed hosts. Lower ID50 indicates higher infectivity.

• LD50 (Lethal Dose-50): The amount of toxin needed to kill 50% of affected hosts. Lower LD50 means higher toxicity.

• R-naught (R₀): The average number of secondary infections produced by one infected individual in a susceptible population. High R₀ values suggest epidemic potential.

Equations:

• ID50 and LD50 are determined experimentally by exposing groups of hosts to varying doses and recording infection or death rates.

• R₀ is calculated as:

Toxins: Endotoxins and Exotoxins

Toxins are microbial products that damage host tissues or disrupt physiological processes. They are classified as endotoxins or exotoxins based on their origin and properties.

• Endotoxins: Lipid A component of lipopolysaccharide (LPS) in Gram-negative bacteria; released upon cell lysis. Causes fever and septic shock, not easily neutralized.

• Exotoxins: Soluble proteins secreted by Gram-positive and Gram-negative bacteria; highly potent and often target specific cellular processes. Can sometimes be neutralized by antitoxins or vaccines.

Table: Comparison of Endotoxins and Exotoxins

5 Steps to Infection

Pathogenesis typically involves a series of steps that enable a microbe to establish infection and spread.

1. Entry: Pathogens enter the host via portals such as skin, respiratory tract, gastrointestinal tract, urogenital tract, or transplacental route.

2. Adherence: Attachment to host tissues using adhesins (e.g., pili, fimbriae, capsules).

3. Invasion and Nutrient Acquisition: Penetration of tissues and acquisition of nutrients using enzymes like invasins, collagenases, neuraminidases, coagulases, and kinases.

4. Evasion of Immune Defenses: Strategies include biofilm formation, antigen masking, antigen mimicry, antigen variation, and capsule production.

5. Transmission: Exit from the host and spread to new hosts via sneezing, coughing, wound exudate, or bodily fluids.

Example: Neisseria gonorrhoeae uses pili to adhere to urogenital tract cells and produces enzymes to invade tissues.

Biosafety Levels (BSL) in Laboratory and Healthcare Settings

Biosafety levels define containment practices for handling infectious agents in laboratories and healthcare environments.

• BSL-1: Minimal risk; standard hygiene practices. Example: Bacillus subtilis, E. coli K-12.

• BSL-2: Moderate risk; pathogens not typically airborne. Example: Staphylococcus aureus, influenza virus, HIV.

• BSL-3: Serious or lethal risk; often airborne. Example: Mycobacterium tuberculosis, Coxiella burnetii.

• BSL-4: High risk; exotic agents with no available treatments. Example: Ebola virus, Marburg virus.

Transmission and Standard Precautions

Infection control relies on standard and transmission-based precautions to prevent the spread of infectious agents.

• Universal (Standard) Precautions: Basic infection control measures including hand hygiene, use of personal protective equipment (PPE) such as gloves, gowns, and masks, safe handling of sharps, and surface disinfection.

• Transmission-Based Precautions: Additional measures for specific pathogens to prevent contact, droplet, and airborne transmission.

Example: Airborne precautions are used for tuberculosis, while contact precautions are used for methicillin-resistant Staphylococcus aureus (MRSA).

Key Terms

• Normal microbiota

• Mutualism

• Dysbiosis

• Pathogen

• Opportunistic pathogen

• Tropism

• Pathogenicity

• Virulence

• Virulence factor

• ID50

• LD50

• R-naught (R₀)

• Endotoxin

• Exotoxin

• Adhesins

• Invasins

• Antigen masking

• Antigen mimicry

• Antigen variation

• Biofilm

• Biosafety level (BSL)

• Universal precautions

• Transmission precautions